Logo image of ACNT

ASCENT INDUSTRIES CO (ACNT) Stock Fundamental Analysis

NASDAQ:ACNT - US8715651076 - Common Stock

12.22 USD
+0.28 (+2.35%)
Last: 8/29/2025, 8:05:17 PM
12.22 USD
0 (0%)
After Hours: 8/29/2025, 8:05:17 PM
Fundamental Rating

4

Taking everything into account, ACNT scores 4 out of 10 in our fundamental rating. ACNT was compared to 156 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for ACNT as it has an excellent financial health rating, but there are worries on the profitability. ACNT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ACNT has reported negative net income.
ACNT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACNT reported negative net income in multiple years.
Each year in the past 5 years ACNT had a positive operating cash flow.
ACNT Yearly Net Income VS EBIT VS OCF VS FCFACNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

With a Return On Assets value of -2.60%, ACNT perfoms like the industry average, outperforming 46.79% of the companies in the same industry.
ACNT has a Return On Equity of -3.55%. This is comparable to the rest of the industry: ACNT outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -2.6%
ROE -3.55%
ROIC N/A
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ACNT Yearly ROA, ROE, ROICACNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

The Gross Margin of ACNT (18.41%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ACNT has grown nicely.
The Profit Margin and Operating Margin are not available for ACNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
ACNT Yearly Profit, Operating, Gross MarginsACNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

8

2. Health

2.1 Basic Checks

ACNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACNT has less shares outstanding than it did 1 year ago.
ACNT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACNT has been reduced compared to a year ago.
ACNT Yearly Shares OutstandingACNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACNT Yearly Total Debt VS Total AssetsACNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ACNT has an Altman-Z score of 4.37. This indicates that ACNT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ACNT (4.37) is better than 69.87% of its industry peers.
ACNT has a debt to FCF ratio of 0.26. This is a very positive value and a sign of high solvency as it would only need 0.26 years to pay back of all of its debts.
The Debt to FCF ratio of ACNT (0.26) is better than 93.59% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ACNT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.01, ACNT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.26
Altman-Z 4.37
ROIC/WACCN/A
WACC10.29%
ACNT Yearly LT Debt VS Equity VS FCFACNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

ACNT has a Current Ratio of 6.64. This indicates that ACNT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACNT (6.64) is better than 86.54% of its industry peers.
ACNT has a Quick Ratio of 6.13. This indicates that ACNT is financially healthy and has no problem in meeting its short term obligations.
ACNT's Quick ratio of 6.13 is amongst the best of the industry. ACNT outperforms 85.90% of its industry peers.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 6.13
ACNT Yearly Current Assets VS Current LiabilitesACNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.91% over the past year.
Looking at the last year, ACNT shows a very negative growth in Revenue. The Revenue has decreased by -20.35% in the last year.
Measured over the past years, ACNT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.24% on average per year.
EPS 1Y (TTM)85.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%811.11%
Revenue 1Y (TTM)-20.35%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-62.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACNT Yearly Revenue VS EstimatesACNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ACNT Yearly EPS VS EstimatesACNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2023 2024 2025 0 1 -1 -2 -3 -4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACNT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 14.98, which indicates a correct valuation of ACNT.
Based on the Price/Forward Earnings ratio, ACNT is valued a bit cheaper than 64.74% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.76. ACNT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.98
ACNT Price Earnings VS Forward Price EarningsACNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACNT is valued a bit cheaper than the industry average as 63.46% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ACNT is valued cheaply inside the industry as 90.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.37
EV/EBITDA 12.81
ACNT Per share dataACNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASCENT INDUSTRIES CO

NASDAQ:ACNT (8/29/2025, 8:05:17 PM)

After market: 12.22 0 (0%)

12.22

+0.28 (+2.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners38.63%
Inst Owner ChangeN/A
Ins Owners18.87%
Ins Owner Change-12.76%
Market Cap114.50M
Analysts85.71
Price TargetN/A
Short Float %4.19%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-59.14%
Min Revenue beat(2)-67.86%
Max Revenue beat(2)-50.42%
Revenue beat(4)0
Avg Revenue beat(4)-39.34%
Min Revenue beat(4)-67.86%
Max Revenue beat(4)-14.07%
Revenue beat(8)1
Avg Revenue beat(8)-25.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.98
P/S 0.9
P/FCF 13.37
P/OCF 11.28
P/B 1.28
P/tB 1.32
EV/EBITDA 12.81
EPS(TTM)-0.63
EYN/A
EPS(NY)0.82
Fwd EY6.68%
FCF(TTM)0.91
FCFY7.48%
OCF(TTM)1.08
OCFY8.87%
SpS13.55
BVpS9.57
TBVpS9.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.6%
ROE -3.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.41%
FCFM 6.75%
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
F-Score8
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.26
Debt/EBITDA 0.2
Cap/Depr 27.36%
Cap/Sales 1.25%
Interest Coverage N/A
Cash Conversion 231.11%
Profit Quality N/A
Current Ratio 6.64
Quick Ratio 6.13
Altman-Z 4.37
F-Score8
WACC10.29%
ROIC/WACCN/A
Cap/Depr(3y)34.33%
Cap/Depr(5y)30.57%
Cap/Sales(3y)1.26%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%811.11%
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.35%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-62.84%
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y94.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year361.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.2%
FCF growth 3Y-10.03%
FCF growth 5Y-11.9%
OCF growth 1Y-51.08%
OCF growth 3Y-8.33%
OCF growth 5Y-12.51%